Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,904 | -164,076 | -127,997 | -92,475 | -50,882 |
| Depreciation Amortization | -1,512 | 1,026 | -2,790 | -1,553 | -898 |
| Accounts payable and accrued liabilities | -934 | -625 | 4,168 | 2,886 | 6,410 |
| Other Working Capital | -68 | -37,016 | -13,892 | -3,727 | -146 |
| Other Operating Activity | 3,120 | -7,820 | -3,041 | 78 | -3,537 |
| Operating Cash Flow | $-44,298 | $-208,511 | $-143,552 | $-94,791 | $-49,053 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -329 | -719 | N/A | N/A |
| PPE Investments | -18 | -171 | -153 | -39 | -2 |
| Net Acquisitions | N/A | -697 | N/A | N/A | N/A |
| Purchase Of Investment | -452,253 | N/A | N/A | -43,852 | -24,931 |
| Sale Of Investment | 101,482 | N/A | N/A | 137,892 | 69,319 |
| Other Investing Activity | 0 | 0 | -697 | -697 | -697 |
| Investing Cash Flow | $-350,789 | $-1,197 | $-1,569 | $93,304 | $43,689 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 529,574 | 181,716 | 143,045 | 218 | 7 |
| Other Financing Activity | -25 | -1,150 | -1,150 | 0 | 0 |
| Financing Cash Flow | $529,549 | $180,566 | $141,895 | $218 | $7 |
| Exchange Rate Effect | N/A | 6 | 6 | 5 | -1 |
| Beginning Cash Position | 15,116 | 44,252 | 44,252 | 44,252 | 44,252 |
| End Cash Position | 149,578 | 15,116 | 41,032 | 42,988 | 38,894 |
| Net Cash Flow | $134,462 | $-29,136 | $-3,220 | $-1,264 | $-5,358 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,298 | -208,511 | -143,552 | -94,791 | -49,053 |
| Capital Expenditure | -18 | -171 | -153 | -39 | -2 |
| Free Cash Flow | -44,316 | -208,682 | -143,705 | -94,830 | -49,055 |